The Latest Breaking News from Prostate Cancer UK

At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects

It comes as concerns were raised that a new drug approved for NHS use will not be given to eligible patients.

With the backing of Rishi Sunak, Prostate Cancer UK published a report to the national screening committee back in 2022 in support of a targeted program for men at ‘high risk’. So, who are they – and will the government listen? Rebecca Thomas reports

Concerns have also been raised about the proportion of men who were only diagnosed after their disease had spread

Prostate Cancer UK also raised concerns about the proportion of men who were only diagnosed after their disease had spread.

Campaigners seek to raise awareness that twice as many black men are getting the disease than white men

Prostate Cancer UK said it shows how the earlier you find the disease, the easier it is to treat.

The scan only takes 15 to 20 minutes and could save the NHS money, researchers say.

Olympic legend hails a 'truly extraordinary day' in support of cancer charities